Cargando…

Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings

Detalles Bibliográficos
Autores principales:	Cho, Janice M., Pestana, Laura, Pardi, Ryan, Pardi, Darrell S., Khanna, Sahil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667362/ https://www.ncbi.nlm.nih.gov/pubmed/31117340 http://dx.doi.org/10.5217/ir.2019.00056

Ejemplares similares

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations
por: Khanna, Sahil, et al.
Publicado: (2021)

Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2023)

Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study
por: Saha, Srishti, et al.
Publicado: (2020)

Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study
por: Saha, Srishti, et al.
Publicado: (2023)

Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection
por: Saha, Srishti, et al.
Publicado: (2021)

Clostridioides difficile infection: curbing a difficult menace
por: Khanna, Sahil, et al.
Publicado: (2022)

Intraprocedure Artificial Intelligence Alert System for Colonoscopy Examination
por: Hsu, Chen-Ming, et al.
Publicado: (2023)

Outcomes in children with Clostridium difficile infection: results from a nationwide survey
por: Gupta, Arjun, et al.
Publicado: (2016)

Tetracyclines are Associated with a Reduced Risk of Clostridium difficile Infection: A Systematic Review and Meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2017)

In reply—Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates
por: Tariq, Raseen, et al.
Publicado: (2021)

Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease
por: Khanna, Sahil, et al.
Publicado: (2017)

1620 Extraintestinal Clostridium difficile infections: A Single Center Experience
por: Gupta, Arjun, et al.
Publicado: (2014)

Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
por: Voth, Elida, et al.
Publicado: (2021)

Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2018)

Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice
por: Tariq, Raseen, et al.
Publicado: (2017)

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2020)

Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
por: Sehgal, Kanika, et al.
Publicado: (2021)

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
por: Khanna, Sahil, et al.
Publicado: (2020)

Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2021)

The natural history of histological changes in microscopic colitis
por: Sehgal, Kanika, et al.
Publicado: (2023)

A268 RESOLUTION RATES IN OPEN-LABEL VERSUS RANDOMIZED CONTROLLED TRIALS FOR MICROBIOTA RESTORATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: AN UPDATED META-ANALYSIS
por: Tariq, R, et al.
Publicado: (2023)

Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2
por: Yadav, Devvrat, et al.
Publicado: (2021)

Weight Gain After Fecal Microbiota Transplantation
por: Alang, Neha, et al.
Publicado: (2015)

Fecal Microbiota Transplantation May Represent a Good Approach for Patients with Focal Segmental Glomerulosclerosis: A Brief Report
por: Zhi, Wenqiang, et al.
Publicado: (2022)

Minimum Requirements for Reporting Fecal Microbiota Transplant Trial
por: Moossavi, Shirin, et al.
Publicado: (2015)

Mobile 3D Intraprocedural Fluoroscopy in Combination With Ultrathin Bronchoscopy for Biopsy of Peripheral Lung Nodules
por: Sadoughi, Ali, et al.
Publicado: (2021)

Biologics: how far can they go in Crohn’s disease?
por: Dunleavy, Katie A, et al.
Publicado: (2022)

Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
por: Stripling, Joshua, et al.
Publicado: (2015)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Drug-induced Erythema Multiforme Major in an Elderly Female
por: Patel, Roshniben, et al.
Publicado: (2022)

Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process
por: Xu, Yinghui, et al.
Publicado: (2015)

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
por: Quagliariello, Andrea, et al.
Publicado: (2020)

Can Colonoscopy Aspirates be a Substitute for Fecal Samples in Analyses of the Intestinal Microbiota?
por: KEREN, Nirit, et al.
Publicado: (2012)

Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults
por: Alhuzaim, Waleed M, et al.
Publicado: (2023)

658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practice vs Clinical Trials
por: Sims, Matthew, et al.
Publicado: (2021)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports
por: Zhao, Jin, et al.
Publicado: (2021)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Gut Microbial Changes Following Fecal Microbiota Transplantation for D-Lactic Acidosis in Two Children
por: Busing, Jordan D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oer89fv87pkrjbcj17r8k6rid0